Veeco Instruments Inc. is a manufacturer of advanced semiconductor and compound semiconductor process equipment. The company provides ion beam, laser annealing, metal organic chemical vapor deposition (MOCVD), chemical vapor deposition (CVD), advanced packaging lithography, single wafer wet processing, molecular beam epitaxy (MBE), and atomic layer deposition (ALD) technologies. Its systems are used in the fabrication of logic and memory chips, RF filters, power electronics, photonics devices, and magnetic heads for hard disk drives. Veeco serves four primary end-markets: Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other. The company operates sales and service operations across the Asia-Pacific, Europe, and North America regions. Veeco was organized as a Delaware corporation in 1989 following a management buyout of Vacuum Electronic Equipment Co., which was founded in 1945. The company acquired Ion Tech, Applied EPI, Emcore, Solid State Equipment, and Ultratech to expand its technology portfolio. In September 2025, Veeco entered into a merger agreement with Axcelis Technologies, Inc., under which Veeco will become a wholly-owned subsidiary of Axcelis.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Semiconductor Equipment & Materials Homepage veeco.com
Sector Technology IR page ir.veeco.com/home/default.aspx
Tags
ion beam deposition, laser annealing, mocvd, chemical vapor deposition, advanced packaging, molecular beam epitaxy, atomic layer deposition, wet processing, compound semiconductors, data storage, photonics, rf filters, Ion Tech, Applied EPI, Emcore, Solid State Equipment, Ultratech, Axcelis Technologies, TurboDisc MaxBright, SPECTOR-HT, GENxplor, EPIK 700, WaferStorm, TurboDisc K475i, LSA101
Press page veeco.com/company/news

Metrics

Valuation  
Market cap $ 2.445B
Market cap (USD) $ 2.445B
P/E 100.00
PEG —
P/BV 2.65
P/S 3.37
P/OCF 17.19
P/FCF 19.44
Dividend yield —
Turnover / mcap —
Returns  
ROE 4.3%
ROI 3.2%
ROIC 2.9%
Profit margin 5.3%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -40.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 24.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 25
Quality score -33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 664.294M 717.301M 666.435M 646.137M 583.277M 454.163M 419.349M 542.082M 484.756M 332.451M 477.038M 392.873M 331.749M 516.02M 979.135M 930.892M 380.149M 442.809M 402.475M 441.034M 410.19M 390.443M 279.321M 298.885M 449.251M 386.668M
Net profit 35.39M 73.714M -30.368M 166.942M 26.038M -8.391M -78.733M -407.088M -44.793M -122.21M -31.978M -66.94M -42.263M 30.928M 127.987M 361.76M -15.567M -71.063M -17.359M 14.917M -897K -62.555M -9.747M -123.73M 10.309M -17.88M
Free cash flow 53.293M 45.702M 33.744M 83.879M 27.099M 36.219M -18.289M -50.392M 9.874M -35.323M 1.902M 26.481M -8.447M 86.969M 55.078M 183.49M 49.502M 31.458M 30.093M 28.614M 33.234M -14.477M 13.693M -10.801M 2.563M -7.498M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 28.58 26.8 31.03 18.58 28.47 17.36 14.69 7.41 14.85 29.15 20.56 34.88 32.91 29.49 20.8 42.97 33.21 15.46 — 22.66 — — — — — —
Price performance 12m 0.07 -0.14 0.67 -0.35 0.64 0.18 0.98 -0.5 -0.49 0.42 -0.41 0.06 0.12 0.42 -0.52 0.29 1.15 — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 58M 98.9M 66.8M 45.7M 80M 110M 124M 103M 96.8M 111M
↳ YoY growth +17.2% +70.4% -32.4% -31.6% +75.2% +37.0% +13.3% -17.1% -6.0% +14.3%
↳ 5y CAGR -9.4% +9.4% +22.9% -5.3% +10.1% +13.6% +4.7% +9.0% +16.2% +6.7%
Borrowings, current (USD) 368,000 — — — — — 20.2M — 26.5M —
Borrowings, non-current (USD) 826,000 276M 287M 300M 321M 229M 254M 275M 250M 226M
Lease liabilities (USD) — — — 14.5M 10.5M 37.3M 36.9M 35.6M 38.1M 36M
Cash and deposits (USD) 277M 280M 212M 129M 130M 120M 155M 159M 146M 163M
Intangible assets (USD) 58.4M 370M 85.1M 61.5M 46.2M 33.9M 23.9M 43.9M 8.83M 5.7M
Right-of-use assets (USD) — — — 14.5M 10.3M 28.8M 26.5M 24.4M 26.5M 24.6M
Net debt (borrowings + leases - cash) (USD) -276M -4.11M 75.1M 185M 202M 147M 157M 152M 169M 98.5M
Cash flow detail
Operating cash flow (USD) -23.8M 34.1M -37.7M -7.42M 43M 67.7M 108M 61.7M 63.8M 69.5M
Purchases of property, plant and equipment (USD) -11.5M -24.3M -12.7M -10.9M -6.8M -40.6M -24.6M -27.9M -18.1M -16.2M
Change in receivables (cash effect) (USD) -8.67M 4.52M — — — — — — — —
Change in inventories (cash effect) (USD) -5.39M 6.34M -24.7M 15M -11.5M -24.8M -37.3M -35.2M -8.31M -28.6M
Change in payables (cash effect) (USD) -24.2M 12.2M -19.7M -26.9M 16M 20.2M -13.1M -8.81M -338,000 4.23M
Share buybacks (cash effect) (USD) -13.3M -2.87M -11.5M — — — — — — —
Interest paid (cash effect) (USD) -225,000 -4.68M -9.71M -9.41M -12.7M -12.6M -10.1M -11.8M -9.5M -8.23M
Income taxes paid (cash effect) (USD) -1.7M -1.94M -4.8M -2.93M -329,000 139,000 -1.43M -5.1M -3.03M -87,000
Share-based compensation (USD) 15.7M 24.4M 16.1M 15.3M 12.7M 15.2M 23M 28.6M 35.9M 37M
Operating cash flow before change in receivables (USD) -15.2M 29.6M — — — — — — — —
Free cash flow (OCF - PPE - intangibles) (USD) -35.3M 9.87M -50.4M -18.3M 36.2M 27.1M 83.9M 33.7M 45.7M 53.3M
Income detail
Research and development expense (USD) 81M 82M 97.8M 90.6M 79M 88.7M 104M 113M 125M 120M
↳ 5y CAGR -3.5% -2.9% +3.7% +2.2% +0.1% +1.8% +4.8% +2.9% +6.6% +8.7%
Total comprehensive income (USD) -122M -44.8M -407M -78.7M -8.44M 25.7M 166M -29.7M 73.6M 35.7M
Comprehensive income to owners (USD) -122M -44.8M -407M -78.7M -8.44M 25.7M 166M -29.7M 73.6M 35.7M
Provision for credit losses (USD) 171,000 99,000 — 392,000 140,000 — — 316,000 — —
Credit cost ratio (credit losses / average receivables) (%) 0.3% 0.1% — 0.7% 0.2% — — 0.3% — —
Reported Feb 22, 2017 Feb 21, 2018 Feb 25, 2019 Feb 21, 2020 Feb 22, 2021 Feb 18, 2022 Feb 22, 2023 Feb 16, 2024 Feb 14, 2025 Feb 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

VEECO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS Bull 3 Bear 0 Results

November 4, 2026

Third Quarter 2026 Highlights:

  • Revenue of $209.4 million, compared with $165.9 million in the same period last year
  • GAAP net income of $13.6 million, or $0.21 per diluted share, compared with $10.6 million, or $0.17 earnings per diluted share in the same period last year
  • Non-GAAP net income of $24.1 million, or $0.36 per diluted share, compared with $21.8 million, or $0.36 per diluted share in the same period last year

PLAINVIEW, N.Y., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2026. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.  

U.S. Dollars in millions, except per share data
GAAP Results Q3 '26 Q3 '25
Revenue $ 209.4 $ 165.9
Net income $ 13.6 $ 10.6
Diluted earnings per share $ 0.21 $ 0.17
Non-GAAP Results Q3 '26 Q3 '25
Operating income $ 25.2 $ 23.1
Net income $ 24.1 $ 21.8
Diluted earnings per share $ 0.36 $ 0.36

“Veeco’s third-quarter performance reflects solid execution and significant opportunities across our business,” said Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “AI infrastructure investment is accelerating technology transitions across leading-edge logic and memory, advanced packaging, and high-speed optical connectivity. This is driving unprecedented customer engagement and order activity across our differentiated portfolio. With greater visibility and strategic investments to expand our manufacturing capacity, we believe Veeco is well positioned to exceed one billion dollars in revenue for the full year 2027.”

Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2026:

  • Revenue is expected in the range of $230 million to $260 million
  • GAAP diluted earnings per share are expected in the range of $0.34 to $0.53
  • Non-GAAP diluted earnings per share are expected in the range of $0.50 to $0.70

The following revised guidance is provided for Veeco’s fiscal year 2026:

  • Revenue is expected in the range of $790 million to $820 million
  • GAAP diluted earnings per share are expected in the range of $0.72 to $0.92
  • Non-GAAP diluted earnings per share are expected in the range of $1.32 to $1.52

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 4, 2026 starting at 5:00pm ET. To join the call, dial 1-888-396-8049 or 1-416-764-8646. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com . A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com .

No Offer or Solicitation

This communication is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, including trends related to artificial intelligence and high-performance computing, industry outlooks and demand drivers, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments currently being held by U.S. Customs, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:
Investor Relations: Alex Delacroix (516) 528-1020 [email protected]
Media: Brenden Wright (410) 984-2610 [email protected]
Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited)
Three months ended September 30, Nine months ended September 30,
2026 2025 2026 2025
Net sales $ 209,384 $ 165,881 $ 561,206 $ 499,277
Cost of sales 128,995 98,178 350,157 294,380
Gross profit 80,389 67,703 211,049 204,897
Operating expenses, net:
Research and development 35,059 28,988 98,277 89,062
Selling, general, and administrative 28,534 24,654 82,179 73,609
Amortization of intangible assets 411 771 1,723 2,413
Merger costs 2,260 2,609 5,736 2,609
Other operating expense (income), net 26 127 (160 ) 132
Total operating expenses, net 66,290 57,149 187,755 167,825
Operating income 14,099 10,554 23,294 37,072
Interest income (expense), net 1,785 1,321 4,131 3,062
Other income (expense), net — — — (653 )
Income before income taxes 15,884 11,875 27,425 39,481
Income tax expense 2,249 1,279 2,257 5,205
Net income $ 13,635 $ 10,596 $ 25,168 $ 34,276
Income per common share:
Basic $ 0.22 $ 0.18 $ 0.41 $ 0.58
Diluted $ 0.21 $ 0.17 $ 0.39 $ 0.57
Weighted average number of shares:
Basic 61,109 60,077 60,889 58,993
Diluted 66,154 60,950 65,207 60,436
Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in thousands)
September 30, December 31,
2026 2025
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 205,321 $ 163,466
Short-term investments 277,184 226,763
Accounts receivable, net 154,064 110,685
Contract assets 26,884 34,838
Inventories 308,265 275,298
Prepaid expenses and other current assets 43,875 34,286
Total current assets 1,015,593 845,336
Property, plant and equipment, net 116,163 108,646
Operating lease right-of-use assets 24,715 24,606
Intangible assets, net 3,973 5,696
Goodwill 214,964 214,964
Deferred income taxes 123,538 122,935
Other assets 6,714 3,612
Total assets $ 1,505,660 $ 1,325,795
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable $ 68,474 $ 55,345
Accrued expenses and other current liabilities 60,628 45,503
Contract liabilities 132,351 74,161
Income taxes payable 1,041 3,048
Total current liabilities 262,494 178,057
Deferred income taxes 458 532
Long-term debt 226,835 226,009
Long-term operating lease liabilities 31,480 31,837
Other liabilities 60,471 3,852
Total liabilities 581,738 440,287
Total stockholders’ equity 923,922 885,508
Total liabilities and stockholders’ equity $ 1,505,660 $ 1,325,795

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with GAAP. These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2026) (in thousands) (unaudited)
Non-GAAP Adjustments
Share-Based
Three months ended September 30, 2026 GAAP Compensation Amortization Other Non-GAAP
Net sales $ 209,384 $ 209,384
Gross profit 80,389 1,411 81,800
Gross margin 38.4 % 39.1 %
Operating expenses 66,290 (7,003 ) (411 ) (2,260 ) 56,616
Operating income 14,099 8,414 411 2,260 ^ 25,184
Net income 13,635 8,414 411 1,643 ^ 24,103

^ - See table below for additional details.

Other Non-GAAP Adjustments (Q3 2026) (in thousands) (unaudited)
Three months ended September 30, 2026
Merger related expenses $ 2,260
Subtotal 2,260
Non-cash interest expense 292
Non-GAAP tax adjustment * (909 )
Total Other $ 1,643

* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2026) (in thousands, except per share amounts) (unaudited)
Three months ended September 30, 2026
GAAP Non-GAAP
Numerator:
Net income available to common shareholders $ 13,635 $ 24,103
Denominator:
Basic weighted average shares outstanding 61,109 61,109
Effect of potentially dilutive share-based awards 1,756 1,756
Dilutive effect of 2029 Convertible Senior Notes 3,289 3,289
Diluted weighted average shares outstanding 66,154 66,154
Net income per common share:
Basic $ 0.22 $ 0.39
Diluted $ 0.21 $ 0.36
Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2025) (in thousands) (unaudited)
Non-GAAP Adjustments
Share-based
Three months ended September 30, 2025 GAAP Compensation Amortization Other Non-GAAP
Net sales $ 165,881 $ 165,881
Gross profit 67,703 1,771 69,474
Gross margin 40.8 % 41.9 %
Operating expenses 57,149 (7,374 ) (771 ) (2,663 ) 46,341
Operating income 10,554 9,145 771 2,663 ^ 23,133
Net income 10,596 9,145 771 1,261 ^ 21,773

^ - See table below for additional details.

Other Non-GAAP Adjustments (Q3 2025) (in thousands) (unaudited)
Three months ended September 30, 2025
Merger related expenses 2,609
Other $ 54
Subtotal 2,663
Non-cash interest expense 283
Non-GAAP tax adjustment * (1,685 )
Total Other $ 1,261

* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2025) (in thousands, except per share amounts) (unaudited)
Three months ended September 30, 2025
GAAP Non-GAAP
Numerator:
Net income available to common shareholders $ 10,596 $ 21,773
Denominator:
Basic weighted average shares outstanding 60,077 60,077
Effect of potentially dilutive share-based awards 873 873
Diluted weighted average shares outstanding 60,950 60,950
Net income per common share:
Basic $ 0.18 $ 0.36
Diluted $ 0.17 $ 0.36

(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q3 2026 and 2025) (in thousands) (unaudited)
Three months ended Three months ended
September 30, 2026 September 30, 2025
GAAP Net income $ 13,635 $ 10,596
Share-based compensation 8,414 9,145
Amortization 411 771
Merger related expenses 2,260 2,609
Interest (income) expense, net (1,785 ) (1,321 )
Other — 54
Income tax expense (benefit) 2,249 1,279
Non-GAAP Operating income $ 25,184 $ 23,133

Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2026)
(in millions, except per share amounts)
(unaudited)

Non-GAAP Adjustments
Guidance for the three months ending Share-based
December 31, 2026 GAAP Compensation Amortization Other Non-GAAP
Net sales $ 230 - $ 260 $ 230 - $ 260
Gross profit 97 - 114 2 — — 99 - 116
Gross margin 42 % - 44 % 43 % - 44 %
Operating expenses 73 - 75 (8 ) — (1 ) 64 - 66
Operating income 24 - 39 10 1 35 - 50
Net income $ 23 - $ 36 10 — 1 $ 34 - $ 47
Income per diluted common share $ 0.34 - $ 0.53 $ 0.50 - $ 0.70
Income per Diluted Common Share (Q4 2026) (in millions, except per share amounts) (unaudited)
Guidance for the three months ending December 31, 2026 GAAP Non-GAAP
Numerator:
Net income available to common shareholders $ 23 - $ 36 $ 34 - $ 47
Denominator:
Basic weighted average shares outstanding 61 - 61 61 - 61
Effect of potentially dilutive share-based awards 2 - 2 2 - 2
Dilutive effect of 2029 Convertible Senior Notes 3 - 3 3 - 3
Diluted weighted average shares outstanding 66 - 66 66 - 66
Net income per common share:
Income per diluted common share $ 0.34 - $ 0.53 $ 0.50 - $ 0.70
Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q4 2026) (in millions) (unaudited)
Guidance for the three months ending December 31, 2026
GAAP Net income $ 23 - $ 36
Share-based compensation 10 - 10
Merger related expense 1 - 1
Interest expense (income) (2 ) - (2 )
Income tax expense 3 - 5
Non-GAAP Operating income $ 35 - $ 50

Note: Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to Non-GAAP Financial Data (FY 2026) (in millions, except per share amounts) (unaudited)
Non-GAAP Adjustments
Guidance for the year ending Share-based
December 31, 2026 GAAP Compensation Amortization Other Non-GAAP
Net sales $ 790 - $ 820 $ 790 - $ 820
Gross profit 309 - 325 6 — — 315 - 331
Gross margin 39 % - 40 % 40 % - 40 %
Operating expenses 261 - 262 (30 ) (2 ) (7 ) 222 - 224
Operating income 48 - 63 36 2 7 93 - 108
Net income $ 48 - $ 62 36 2 2 $ 89 - $ 102
Income per diluted common share $ 0.72 - $ 0.92 $ 1.32 - $ 1.52
Income per Diluted Common Share (FY 2026) (in millions, except per share amounts) (unaudited)
Guidance for the year ending December 31, 2026 GAAP Non-GAAP
Numerator:
Net income available to common shareholders $ 48 - $ 62 $ 89 - $ 102
Denominator:
Basic weighted average shares outstanding 61 - 61 61 - 61
Effect of potentially dilutive share-based awards 2 - 2 2 - 2
Dilutive effect of 2029 Convertible Senior Notes 3 - 3 3 - 3
Diluted weighted average shares outstanding 66 - 66 66 - 66
Net income per common share:
Income per diluted common share $ 0.72 - $ 0.92 $ 1.32 - $ 1.52
Reconciliation of GAAP Net Income to Non-GAAP Operating Income (FY 2026) (in millions) (unaudited)
Guidance for the year ending December 31, 2026
GAAP Net income $ 48 - $ 62
Share-based compensation 36 - 36
Amortization 2 - 2
Merger related expense 7 - 7
Interest expense (income) (6 ) - (6 )
Income tax expense 6 - 7
Non-GAAP Operating income $ 93 - $ 108

Primary Logo

Source: Veeco Instruments Inc.

View All News

Quick Links

IR Contact

Alex Delacroix
Investor Relations
[(516) 528 1020](tel:(516) 528 1020)

[email protected]

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Veeco Instruments Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Veeco Instruments Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address * Investor Alert Options *

News
Events & Presentations
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Captcha
Enter the code shown above.
*

Submit

Submit

Unsubscribe

Email Alert Sign Up Confirmation

REQUEST A MEETING WITH MANAGEMENT

© 2026 Veeco Instruments Inc. - All rights reserved

Powered By Q4 Inc. 5.192.4.2 (opens in new window)

November 2, 2026

Merger now expected to close by the end of the first quarter of 2027

BEVERLY, Mass., and PLAINVIEW, N.Y., November 2, 2026 – Axcelis Technologies, Inc. (Nasdaq: ACLS) (“Axcelis”) and Veeco Instruments Inc. (NASDAQ: VECO) (“Veeco”) today provided an update on the expected timing of the previously disclosed all-stock merger of Axcelis and Veeco. The companies now expect the transaction to close by the end of the first quarter of 2027, subject to the satisfaction or waiver of all closing conditions. There can be no assurances that the closing will occur on this timeline.

The completion of the transactions contemplated by the merger agreement is subject to the satisfaction or waiver of customary closing conditions, including the pending regulatory approval from the State Administration for Market Regulation of the People’s Republic of China (“SAMR”). The parties continue to work constructively with SAMR to obtain clearance.

In addition, due to the pending expiry of the current clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), the parties plan to promptly make a new submission under the HSR Act. The closing is also conditioned upon the expiration or early termination of the HSR Act waiting period for this new submission.

Under the terms of the merger agreement, each share of Veeco common stock will be converted into the 0.3575 Axcelis shares at closing. Together, the combined company is expected to be well positioned as a semiconductor equipment leader serving complementary, diversified and expanding end markets.

About Axcelis

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com .

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco's systems and service offerings, visit www.veeco.com .

Additional Information About the Potential Transaction and Where to Find It

In connection with the proposed Merger between Axcelis and Veeco pursuant to the Merger Agreement, dated as of September 30, 2025, by and between Axcelis, Veeco and Victory Merger Sub, Inc., on December 8, 2025, Axcelis filed with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (File No. 333-292008), as amended on December 29, 2025 (the “Registration Statement”). The Registration Statement was declared effective by the SEC on December 31, 2025. Each of Axcelis and Veeco filed a definitive joint proxy statement/prospectus (the “Joint Proxy Statement/Prospectus”) with the SEC on December 31, 2025 and commenced mailing to their respective stockholders on or about December 31, 2025. Each of Axcelis and Veeco may also file with or furnish to the SEC other relevant documents regarding the proposed Merger. This document is not a substitute for the Joint Proxy Statement/Prospectus or any other document that Axcelis or Veeco has filed or may file with or furnish to the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE OR WILL BE FILED WITH OR FURNISHED TO THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND RELATED MATTERS. Investors and security holders are able to obtain free copies of the Joint Proxy Statement/Prospectus and other documents containing important information about Axcelis, Veeco and the proposed Merger through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with or furnished to the SEC by Axcelis will be available free of charge on Axcelis’ website at investor.axcelis.com or by contacting Axcelis’ Investor Relations department by email at [email protected]. Copies of the documents filed with or furnished to the SEC by Veeco will be available free of charge on Veeco’s website at ir.veeco.com or by contacting Veeco’s Investor Relations department by email at [email protected] .

No Offer or Solicitation

This document is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-Looking Statements

Certain statements included in this document, and any related oral statements, that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Statements in this document other than historical facts, such as statements pertaining to: (i) the expected timing of the closing of the Merger, (ii) future industry demand for semiconductors and wafer fabrication equipment; (iii) future development of regulatory landscape; (iv) Axcelis’ or Veeco’s market position for the future; (v) forecasts of financial measures for future periods; (vi) long-term financial targets and underlying assumptions; (vii) the future investment plan for research and development, technology and infrastructure; (viii) future shareholder returns; and (ix) potential synergies or other benefits of a potential transaction between Axcelis and Veeco, are forward-looking statements.

Any statements that involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events, or performance (often but not always using phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “budget,” “scheduled,” “forecasts,” “estimates,” “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could,” “would,” “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information.

These forward-looking statements are based on current information and assumptions and involve a number of risks and uncertainties, including relating to obtaining applicable regulatory approvals, satisfying other closing conditions to the proposed Merger, the expected tax treatment of the proposed Merger, the expected timing of the proposed Merger and the integration of the businesses and the expected benefits, cost savings, accretion, synergies and growth to result therefrom. These risks include, among other things: failure to obtain applicable regulatory approvals in a timely manner or otherwise; failure to satisfy other closing conditions to the proposed Merger or to complete the proposed Merger on anticipated terms and timing; negative effects of the announcement of the proposed Merger; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the proposed Merger will harm business plans and operations; risks relating to unanticipated costs of integration; significant Merger and/or integration costs, or difficulties in connection with the proposed Merger and/or unknown or inestimable liabilities; restrictions during the pendency of the proposed Merger that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the proposed Merger; the potential impact of the announcement or consummation of the proposed Merger on Axcelis’, Veeco’s or the combined company’s relationships with suppliers, customers, employees and regulators; and demand for the combined company’s products. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: economic, political and social conditions in the countries in which Axcelis and Veeco, their respective customers and suppliers operate; disruption to Axcelis’ and Veeco’s respective manufacturing facilities or other operations, or the operations of Axcelis’ and Veeco’s respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; Axcelis’, Veeco’s and the combined company’s ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry; Axcelis’, Veeco’s and the combined company’s ability to maintain their respective technology advantage and protect their respective proprietary rights; Axcelis’, Veeco’s and the combined company’s ability to compete with new products introduced by their respective competitors; Axcelis’, Veeco’s and the combined company’s ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China.

For other factors that may cause actual results to differ materially from those projected and anticipated in forward-looking statements in this press release, please refer to Axcelis’ most recent Annual Report on Form 10-K and Veeco’s most recent Annual Report on Form 10-K, and other subsequent filings with the SEC made by Axcelis and/or Veeco. Unless required by law, we assume no obligation to, and do not currently intend to, update these forward-looking statements.

Axcelis Contacts

**Investor Relations:
**David Ryzhik
Senior Vice President and Interim CFO
Telephone: (978) 787-2352
Email: [email protected]

**Media:
**Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: [email protected]

Mahmoud Siddig / Andrew Siegel / Greg Klassen
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

**Veeco Contacts
Investor Relations:
**Alex Delacroix
Director, Investor Relations
Telephone: (516) 528 1020
Email: [email protected]

**Media:
**Brenden Wright
Vice President, Communications & HR Operations
Telephone: (410) 984-2610
Email: [email protected]

Jim Golden / Ed Hammond / Jack Kelleher
Collected Strategies | [email protected]

View All News

Quick Links

IR Contact

Alex Delacroix
Investor Relations
[(516) 528 1020](tel:(516) 528 1020)

[email protected]

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Veeco Instruments Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Veeco Instruments Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address * Investor Alert Options *

News
Events & Presentations
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Captcha
Enter the code shown above.
*

Submit

Submit

Unsubscribe

Email Alert Sign Up Confirmation

REQUEST A MEETING WITH MANAGEMENT

© 2026 Veeco Instruments Inc. - All rights reserved

Powered By Q4 Inc. 5.192.4.2 (opens in new window)

October 21, 2026

PLAINVIEW, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) plans to release its third quarter 2026 financial results after the market closes on Wednesday, November 4, 2026. The company will host a conference call to review these results starting at 5:00 PM ET that day.

To join the call, dial (+1) 888-396-8049 (toll-free) or (+1) 416-764-8646. Participants may also access a live webcast of the call by visiting Veeco's investor relations website at ir.vee

co.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00 PM ET that same evening.

Prompts

Veeco Instruments Inc. (ticker VECO), listed in United States.

Company History

Date Change Detail
Apr 28, 2017 Acquired Acquired Ultratech Inc (CIK 909791). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Veeco Instruments Inc.

ETF Weight in ETF Shares Market value As of
GSC 0.96% 60,511 $ 2.681M Aug 31, 2026
MSSM 0.51% 82,036 $ 3.634M Aug 31, 2026
FFSM 0.38% 113,951 $ 5.698M Jul 31, 2026
TMSL 0.31% 112,005 $ 8.49M Jun 30, 2026
RESM 0.24% 115 $ 8,717.00 Jun 30, 2026
SYZ 0.17% 1,562 $ 118.4K Jun 30, 2026
IVSS 0.12% 436 $ 33.049K Jun 30, 2026
AVSC 0.12% 103,612 $ 3.854M Nov 16, 2026
JSTC 0.10% 7,901 $ 293.917K Nov 17, 2026
JMEE 0.07% 54,006 $ 1.984M Nov 17, 2026
DFAS 0.06% 469,627 $ 18.94M Nov 12, 2026
DFAT 0.02% 191,746 $ 7.733M Nov 12, 2026
SMDX 0.02% 652 $ 24.254K Nov 17, 2026
DFAC 0.01% 271,726 $ 10.959M Nov 12, 2026
DXUV 0.01% 16,399 $ 661.372K Nov 12, 2026
AVSU 0.01% 836 $ 31.099K Nov 16, 2026
DFSU 0.01% 5,634 $ 227.219K Nov 12, 2026
DCOR 0.01% 81,211 $ 3.275M Nov 12, 2026
DFAU 0.00% 14,827 $ 597.973K Nov 12, 2026
DFUV 0.00% 16,710 $ 673.914K Nov 12, 2026
DFUS 0.00% 20,757 $ 837.13K Nov 12, 2026
EBI 0.00% 316 $ 13.999K Aug 31, 2026
AVUS 0.00% 9,289 $ 345.551K Nov 16, 2026